BABrian W. Allwood

Brian W. Allwood

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Brian W. Allwood has a total of 330 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Severely reduced antioxidant and impaired mitochondrial biomarkers could be linked to post-tuberculosis lung disease in a cohort from South Africa

    by C Payne, E Louw, N Baines, M Mitrovich, D Maree, C Lombard, B Botha, B Allwood, G J Maarman

    Background. Post-tuberculosis lung disease (PTLD) refers to unresolved lung damage and impaired lung function after successful treatment of tuberculosis (TB). Its pathogenesis is not fully understood, and we hypothesised that antioxidant-oxidant and mitochondrial factors may be instrumental. Objectives. To investigate the involvement of mitochondrial and antioxidant-oxidant biomarkers in TB patients who had had more than one previous TB episode and were in the post-TB stage of disease. Methods. Enzyme-linked immunosorbent assays were conducted on patient serum. Results. Lipid peroxidation (measured with the thiobarbituric acid reactive substances assay) was within the normal range. In contrast, the mitochondrial regulator metallothionein-1 was 240 times lower, catalase activity 7.5 times lower, and superoxide dismutase activity 273 times lower than the normal ranges for these markers. Hypoxia-inducible factor-1-alpha (HIF-1α) was below the limit of detection. The mitochondrial markers were similar across the stratified groups after stratifying the patients based on the number of previous TB episodes. Age positively correlated with the ratio of early diastolic mitral inflow velocity to early diastolic mitral annulus velocity (E/eʹ), a marker of left ventricular filling pressure, and it marginally correlated with pulmonary artery systolic pressure, while there were no other notable correlations. Conclusion. Our data demonstrate that antioxidant enzyme activities are extremely low in post-TB patients. A key mitochondrial protein, HIF-1α, showed no role in this context, which could suggest that these patients are not hypoxic. A novel contributor to PTLD could therefore be a limitation of antioxidant capacity and mitochondrial pathways, which is not linked to the number of previous TB episodes but may highlight the need to consider antioxidant therapy during the post-TB stage. Further research is warranted.


  • Open Access

    An international medical education collaborative to enhance academic and clinical capacity in South Africa: a six-year review of Discovery-Mass General Fellowship

    by Vanessa Bradford Kerry, Brian Allwood, Shrish Budree, Sean Chetty, Neliswa Gogela, Salome Maswime, Sumy Teressa Thomas, Louise C Ivers

    The Government of South Africa has prioritised disease prevention and improved healthcare delivery, but the country remains challenged by disease burdens and inequity of resources across the country, including the availability of clinician-specialists to meet public sector and other needs. To address the need for more physician specialists in the country, Discovery Health of South Africa collaborated with Mass General Hospital in the USA to create a clinical and research fellowship for South African clinician-scientists. We engaged fellows in semi-structured interviews to chronicle their experience in the programme and its impact and challenges. Six fellows were awarded the one-year fellowship between 2014 and 2022. Their specialties were in endocrinology, rheumatology, gastroenterology, anaesthesia, and obstetrics and gynecology. All fellows divided their time between research and clinical observership, with programmes individualised for the fellows and mentors in terms of time dedicated to each. The strengths of the programme included formal educational benefits; advanced research techniques, scholarship, and educational opportunities; clinical exposure; strong mentorship; expanded networks; immersive experiences; and accelerated career paths. Weaknesses comprised a relatively short period of study; challenges to reintegration in South Africa; tight budgets to live in the USA; inability to conduct clinical or hands-on practice in the USA; and desire for formal recognition of their time of study in the programme. The fellows all noted the impact of the programme on their own careers- including increased professional opportunities and expanded networks, as well as deepened commitment to and impact in strengthening the capacity of and breadth of service in South Africa's health system. Despite challenges to the programme, the fellowship showed the impact of and need for more similar scientific and clinical academic training programmes to build capacity in low- and middle-income countries. With persistent global shortages of health workers, creative solutions that build expertise should be further scaled.

  • Open Access

    Proceedings from the Third International Post-Tuberculosis Symposium: expanding the circle

    by B.W. Allwood, S.C. Auld, B. Beko, G.P. Bisson, C.P. Borges de Almeida, A. Byrne, F.C. Chow, A. Davis, S. Defres, M. Drage, et al.

    SUMMARY: In light of the recent growth in interest and knowledge of post-TB sequelae, there were high levels of engagement during the 3rd International Post-Tuberculosis Symposium held in Stellenbosch, South Africa. This multi-disciplinary symposium aimed to: 1) Advocate for greater global awareness of post-TB sequelae and empower TB-affected communities; 2) Advance knowledge by sharing current evidence and identifying key priorities; 3) Foster collaborations by strengthening research networks and developing concrete plans for research driven advocacy; and 4) Advance the field by establishing areas of consensus around diagnosis, care, and management. Guided by a 14-member Steering Committee, 9 academic working groups came together to develop key content for plenary sessions and facilitated workshops related to: Patient Engagement, Epidemiology and Modelling, Pathogenesis, Post-TB Lung Disease; Cardiovascular and Pulmonary Vascular Disease; Central Nervous System and Musculoskeletal Disease; Paediatrics Economic; Social and Psychological Sequelae; and Advocacy, Policy, and Stakeholder Engagement. Each group outlined progress within their respective fields and defined key priorities to focus discussion. The Symposium further catalysed coordinated action for the post-TB community of patients, advocates, clinicians, and researchers to define a clear path towards improving outcomes, reducing inequities, and ensuring TB survivors receive the care and support they deserve.


  • Open Access

    The utility of a smartphone electronic referral application in facilitating telemedicine in pulmonology

    by W Ganya, M S Moolla, N Singh, B Allwood, U Lalla, E M Irusen, C F N Koegelenberg

    Background. A streamlined referral system for respiratory diseases is essential, and telemedicine offers a viable solution, particularly within the public healthcare sector. There is a paucity of data on the utility of the Vula medical referral application in pulmonology, a field that lends itself to telemedicine. Objectives. To perform a 1-year retrospective observational study to assess the Vula medical referral application utility in a tertiary referral centre in Cape Town, South Africa (SA). Methods. This retrospective study was conducted at a large tertiary-level hospital located in Cape Town, SA. All adult patients referred to the Division of Pulmonology at the institution from January to December 2023 via the Vula virtual referral platform were included. During the study period, all physicians who contacted the pulmonology outpatient department (OPD) or the pulmonologist-on-call were requested to use the Vula virtual referral platform. Emergency referrals (e.g. life-threatening haemoptysis) were discussed in person, but details were still uploaded to Vula. Results were extracted from archived data. Results. During the study period, a total of 2 073 adult patients were referred through Vula. Of these, 1 699 referrals (82%) resulted in a working diagnosis or respiratory syndrome requiring further evaluation, identified by either the referring physician or the pulmonologist. The most common reasons for referral were suspected malignancy (n=767, 45%) and post-tuberculosis lung disease (n=170, 10%). Nearly half (868, 42%) of the referrals required only medical advice on further management, or assistance with medical image interpretation. A further 538 patients (26%) were scheduled for diagnostic or therapeutic procedures without an outpatient review. Only 537 patients (26%) were ultimately given an appointment date for further evaluation in the pulmonology OPD. Conclusion. Telemedicine in the form a smartphone electronic referral application significantly improved access to and efficiency of pulmonology services in a resource-constrained environment. Approximately 75% of referrals required either guidance with further medical management, assistance with thoracic imaging interpretation, or diagnostic or therapeutic procedures, significantly reducing the outpatient load.

  • Open Access

    Technical Challenges in Studying Infectious Disease-Associated Pulmonary Hypertension in Low- and Middle-Income Countries with Limited Resources

    by Jennifer van Heerden, Irina Mbanze, Elizabeth Louw, Olukayode Aremu, Anastase Dzudie, Ana Mocumbi, Threnesan Naidoo, Brian Allwood, Friedrich Thienemann

    Background: Pulmonary hypertension (PH) disproportionately affects those residing in low- and middle-income countries (LMICs). Given that these countries also have a high prevalence of infectious diseases, many cases of PH are either directly or indirectly related to infectious etiologies. Despite this correlation, the precise burden of infectious disease-associated PH is largely underappreciated due to a lack of diagnostic resources, a shortage of clinical expertise to carry out right heart catheterization and poor access to healthcare facilities in many low- and middle-income settings. Methods: In this narrative review, we highlight the significant burden of infectious disease-associated PH in LMICs, outline the technical challenges faced by LMICs when diagnosing PH, and propose possible solutions for diagnosing PH in resource-constrained settings. Conclusions: Low-cost and sustainable solutions for infectious disease-associated PH in LMICs should be prioritized. Meaningful solutions require collaborative efforts and capacity building in LMICs.


  • Open Access

    South African Thoracic Society consensus statement on transbronchial lung cryobiopsy for interstitial lung disease

    by C F N Koegelenberg, N Singh, A Esmail, R Hofmeyr, A Graham, B W Allwood, U Lalla, P Goussard, K Dheda

    Background. Surgical lung biopsy (SLB), performed via open lung biopsy or video-assisted thoracoscopic surgery, has traditionally been the gold standard for diagnosing interstitial lung disease (ILD) when histological confirmation is necessary. Transbronchial forceps biopsy, while less invasive, often yields small, artifact-prone specimens that are insufficient for conclusive histopathological analysis. Transbronchial lung cryobiopsy (TBLC) has emerged as a minimally invasive alternative, offering a higher diagnostic yield and superior tissue integrity due to the retrieval of larger, en bloc samples. International societies currently conditionally recommended TBLC as a potential first-line diagnostic tool for ILD, citing its favourable safety profile and diagnostic performance. Technique, procedural environment and complications. TBLC may be performed via flexible bronchoscopy with or without an artificial airway. When an artificial airway is used, general anaesthesia is administered, and a supraglottic device or endotracheal tube facilitates bronchoscope and blocker access. Without an artificial airway, the procedure is conducted under conscious sedation using an oral bite guard. A bronchial blocker is deployed to control bleeding, and biopsies are obtained under fluoroscopic guidance with freezing times of 6 - 10 seconds. At least four adequate samples (>5 mm) are collected. Post-procedure care includes positioning the patient with the biopsied lung in the dependent position and performing imaging to detect pneumothorax. While bleeding and pneumothorax are potential risks, they are generally manageable. Definitive exclusion criteria for TBLC have not yet been established, but characteristics such as severely impaired lung function, pulmonary hypertension and significant comorbidity are associated with adverse events. Conclusion. Although TBLC yields marginally lower diagnostic rates compared with SLB, it remains a cost-effective and safer alternative, particularly in resource-limited settings. The South African Thoracic Society strongly advocates for TBLC as the first-line diagnostic modality in all cases of ILD, where histology is required, provided there are no contraindications. This recommendation is based on the lower cost and morbidity associated with TBLC compared with SLB. An exception is made for patients with non-diffuse or non-peribronchiolar disease who are suitable candidates for SLB and where the procedure is readily available. Strengthening local capacity and expertise in TBLC is crucial for improving ILD diagnostic accuracy in South Africa.


  • Open Access

    Delineating the Significance of Several Inflammatory Markers in a Lung Tuberculosis Cohort During the Active and Post-Tuberculosis Stages of the Disease: An Observational Study in Cape Town, South Africa (2019 to 2024)

    by Chrisstoffel Jumaar, Lindiwe Malefane, Steve Jacobs, Olakunle Sanni, Elize Louw, Nicola Baines, Carmen Payne, Sigrid Schulz, Carl Lombard, Merga Feyasa, et al.

    Background: Pulmonary tuberculosis (TB) frequently leads to long-term lung complications that contribute to increased mortality. Understanding the pathogenesis of post-TB lung impairments is crucial for improving long-term outcomes in TB patients; yet this area remains poorly researched. Methods: Our study assessed circulatory inflammatory markers in patients who completed TB treatment more than one year before enrolment (population 1) and patients receiving in-hospital treatment for active drug-sensitive TB (population 2). Results: IL-6 was seven times higher in both populations compared to the normal range. IL-8 was below the limit of detection (LOD) in population 1, while it was approximately 2.5 times higher in population 2 compared to the normal range. TNF-α was 21 times higher in population 1 and 19 times higher in population 2 compared to the normal range. CRP was almost 49 times higher in both populations, and IL-1Ra was below the LOD in population 1, while it was ~1.5 times higher in population 2 compared to the normal range. Conclusions: These inflammatory biomarkers correlated well with lung function in the post-TB state, and their high levels suggest a persistent pro-inflammatory state post-TB, which may contribute to post-TB lung disease. More research is warranted to better understand this phenomenon, but these findings may highlight a need to consider anti-inflammatory therapy for patients with post-TB lung disease, especially since these high levels of cytokines can directly contribute to lung damage.


  • Open Access

    The utility of transbronchial cryobiopsy performed under conscious sedation for interstitial lung diseases in a resource- constrained setting

    by A D Buckley, N Singh, B W Allwood, U Lalla, C F N Koegelenberg

    Background. Transbronchial biopsy (TBB) with a cryoprobe, also known as transbronchial lung cryobiopsy (TBLC), has become a well- established modality for sampling lung parenchyma. TBLC is performed under general anaesthesia in the majority of centres, utilising rigid or flexible bronchoscopy. In resource-constrained settings, however, most diagnostic bronchoscopies, including TBB, are performed under conscious sedation with flexible bronchoscopy without the presence of a specialist anaesthetist. Objectives. Given the paucity of evidence on TBLC performed under conscious sedation for interstitial lung diseases (ILD), specifically in a resource-constrained setting, we aimed to describe its utility in a pilot study. Methods. We prospectively enrolled the first 20 patients who underwent TBLC for ILD at a large tertiary hospital in South Africa. All TBLCs were performed under conscious sedation using a cryoprobe. Patients were actively monitored for complications. The final diagnosis and decision regarding need for a surgical biopsy were made at a multidisciplinary meeting that included at least two specialist pulmonologists with an interest in ILD, a thoracic radiologist, and an anatomical pathologist with an interest in ILD. Results. Three patients experienced complications. Two (10%) developed a pneumothorax (neither required any intervention). Bleeding that required 10 minutes of tamponade with the endobronchial blocker was observed in one case. This patient experienced no haemodynamic or respiratory compromise and was discharged the same day. There were no complications arising from the use of conscious sedation. A definitive diagnosis was made in 17/20 (85%) of the patients. Conclusion. TBLC performed at an experienced bronchoscopy centre using a cryoprobe under conscious sedation with a dedicated sedationist was safe and well tolerated. Furthermore, it had a high diagnostic yield, and surgical lung biopsy was avoided in 85% of the patients.


  • Open Access

    Computed tomography chest imaging for the detection of pulmonary hypertension in patients with post-tuberculosis lung disease

    by M Almubarek, E H Louw, S Griffith-Richards, C Ackermann, N Baines, H Thomson, A J K Pecoraro, C F N Koegelenberg, E M Irusen, B W Allwood

    Background. Pulmonary hypertension (PH) after tuberculosis is increasingly recognised as important in high-burden tuberculosis settings. However, the ability of computed tomography (CT) imaging to accurately detect PH remains unclear. Objectives. To evaluate the performance of standard CT measurements in detecting PH in patients with post-tuberculosis lung disease (PTLD), and to determine the potential role of CT imaging as a screening tool in this population. Methods. A retrospective study of patients with PTLD was conducted from January 2019 to September 2021. Adult patients with both a CT chest scan and an echocardiogram performed within 9 months of each other were enrolled. A diagnosis of PH by echocardiography was made if the right ventricular systolic pressure (RVSP) was ≥36 mmHg or the peak tricuspid regurgitant jet velocity (TRVmax) >2.8 m/s. Radiological criteria for PH included a pulmonary artery/ascending aorta (PA/AA) diameter ratio >1, pulmonary artery diameter (PAD) ≥29 mm (males) or ≥27 mm (females), and right ventricle/left ventricle (RV/LV) diameter ratio ≥1.28. Spirometry was also performed. Results. Of 173 patients with PTLD, 52 met the inclusion criteria. Significant correlations were found between the CT-measured PA/AA ratio and RVSP (p=0.0083) and TRVmax (p=0.0582), but not between the CT-measured RV/LV ratio and RVSP (p=0.1729) or TRVmax (p=0.0749). PAD was also significantly correlated with RVSP (p=0.0011) and TRVmax (p=0.0023). The PA/AA ratio identified patients with PH on echocardiography with ~100% sensitivity, 65% specificity and a positive predictive value of 39.1%, indicating a high potential for false-positive diagnosis. The forced vital capacity was 13.7% lower in patients with PH than in those without (p=0.044); however, the forced expiratory volume in 1 second was not statistically different. Conclusion. A low PA/AA ratio can be used to rule out the diagnosis of PH in PTLD, but a high PA/AA ratio requires further investigation for PH.


  • Open Access

    Endothelial Dysfunction Markers Correlate with the Time Since Completion of Tuberculosis Treatment and the Number of Previous Tuberculosis Episodes

    by Chrisstoffel Jumaar, Steve Jacobs, Carmen Payne, Olakunle Sanni, Elize Louw, Nicola Baines, David Maree, Benjamin Botha, Merga Belina Feyasa, Hans Strijdom, et al.

    Background: Despite “successful” treatment, some lung tuberculosis (TB) patients develop long-term lung impairments that includes damage to the parenchyma and reduced function, which may predispose them to diseases like pulmonary hypertension. However, this is not well understood. Therefore, we investigated whether previous or current TB patients would display elevated biomarkers of endothelial dysfunction and vascular remodeling. Methods: We performed assays for ADMA, VCAM-1, VEGF, angiopoietin-1, TBARS, NT-pro-BNP, and cardiac troponin-I. We further stratified the patients based on 1, 2, 3, and >3 previous TB episodes, and 1–5 yrs, 5–10 yrs, 10–15 yrs and >15 yrs after the last TB treatment completion. We also assessed correlations between the biomarkers and the number of previous TB episodes or the time since the completion of the last TB treatment. Results: ADMA was 70 times higher, VEGF was 2000 times higher and angiopoietin-1 was 6500 times higher than the normal range. NT-pro-BNP and cardiac troponin-I were undetected, and TBARS levels were low. There was a positive linear relationship between the number of previous TB episodes and angiopoietin-1, and between VEGF and the number of previous TB episodes. ADMA, VCAM-1 and TBARS exhibited a weak and negative linear association with the number of previous TB episodes. A negligible negative linear association was observed between the time since the completion of the last TB treatment and angiopoietin-1, VEGF and ADMA. Conclusions: Therefore, having >1 previous TB episode, despite the successful completion of TB treatment, associates with an increased risk of endothelial dysfunction/angiogenesis or vascular remodeling.